样式: 排序: IF: - GO 导出 标记为已读
-
Workup and management of liver transplantation in alcohol-related liver disease United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-03-08 Giacomo Germani, Delphine Degré, Christophe Moreno, Patrizia Burra
-
Temporal progression of pancreatic cancer computed tomography findings until diagnosis: A large-scale multicenter study United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-03-07 Masanori Gonda, Atsuhiro Masuda, Takashi Kobayashi, Takao Iemoto, Saori Kakuyama, Takeshi Ezaki, Takuya Ikegawa, Yuichi Hirata, Hidetaka Tsumura, Kyohei Ogisu, Ryota Nakano, Seiji Fujigaki, Takashi Nakagawa, Megumi Takagi, Kodai Yamanaka, Yu Sato, Koichi Fujita, Keisuke Furumatsu, Takao Kato, Arata Sakai, Hideyuki Shiomi, Tsuyoshi Sanuki, Yoshifumi Arisaka, Yoshihiro Okabe, Hirochika Toyama, Keitaro
-
Opioid analgesia and severity of acute pancreatitis: An international multicentre cohort study on pain management in acute pancreatitis United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-03-04 Sanjay Pandanaboyana, Cecilie Siggaard Knoph, Søren Schou Olesen, Michael Jones, James Lucocq, Jayanta Samanta, Rupjyoti Talukdar, Gabriele Capurso, Enrique de-Madaria, Dhiraj Yadav, Ajith K. Siriwardena, John Windsor, Asbjørn Mohr Drewes, Manu Nayar
-
Global trends in incidence and prevalence of achalasia, 1925–2021: A systematic review and meta-analysis United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-03-02 Kwanjoo Lee, Sung Pyo Hong, In Kyung Yoo, Abdullah Özgür Yeniova, Jong Woo Hahn, Min Seo Kim, Soo-Young Yoon, Masoud Rahmati, Jun Hyuk Lee, Myeongcheol Lee, Wonyoung Cho, Dong Keon Yon
-
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-02-28 Mariangela Allocca, Gaia Catalano, Edoardo V. Savarino, María Chaparro, Asaf Levartovsky, George Michalopoulos, Nikos Viazis, Fotis S. Fousekis, Andreas Psistakis, Daniele Noviello, Catarina Neto do Nascimento, Benedicte Caron, Vassiliki Kitsou, Giorgos Bamias, María José García, Eirini Zacharopoulou, Kalliopi Foteinogiannopoulou, Ferdinando D'Amico, Ioannis Koutroubakis, Pierre Ellul, Maria Tzouvala
-
Intrahepatic splenosis mimicking hepatocellular carcinoma United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-02-28 Martina Rosi, Valentina Adotti, Michele Citone, Fabio Marra
A 50 years-old male outpatient was evaluated for the detection of a hepatic nodule during workup for chronic ALT elevation. The patient had undergone splenectomy for abdominal trauma when he was 14 years old and had evidence of metabolic and alcoholic steatotic liver disease.1 MRI showed marked hepatic fatty infiltration and a mass in the 3rd segment. The nodule was hypointense in T1, isointense in
-
Faecal incontinence with concurrent disorders of gut-brain interaction: A worse outcome United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-02-27 Sarah G. Li, Yoav Mazor, Calvin Joomann Park, Michael P. Jones, Allison Malcolm
-
Manometric identikit of a functioning and effective fundoplication for gastroesophageal reflux disease in the high-resolution manometry ERA United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-02-26 Renato Salvador, Giovanni Capovilla, Matteo Santangelo, Arianna Vittori, Francesca Forattini, Luca Provenzano, Loredana Nicoletti, Andrea Costantini, Lucia Moletta, Michele Valmasoni, Mario Costantini, Edoardo V. Savarino
-
The risk of developing splanchnic vein thrombosis in acute pancreatitis increases 3 days after symptom onset: A systematic review and meta-analysis United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-02-24 Ruben Zsolt Borbély, Eszter Ágnes Szalai, Bryan Mangalath Philip, Dalma Dobszai, Brigitta Teutsch, Ádám Zolcsák, Dániel Sándor Veres, Bálint Erőss, Bálint Gellért, Péter Jenő Hegyi, Péter Hegyi, Nándor Faluhelyi
-
Computer-aided diagnosis in real-time endoscopy for all stages of gastric carcinogenesis: Development and validation study United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-02-24 Eun Jeong Gong, Chang Seok Bang, Jae Jun Lee
-
Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-02-21 Hannes Hagström, Hannes Hegmar, Christophe Moreno
-
Acute decompensation of cirrhosis versus acute-on-chronic liver failure: What are the clinical implications? United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-02-20 Manman Xu, Yu Chen, Florent Artru
-
Symptomatic gallstone disease: Recurrence patterns and risk factors for relapse after first admission, the RELAPSTONE study United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-02-20 Raúl Velamazán, Pablo López-Guillén, Samuel J. Martínez-Domínguez, Daniel Abad Baroja, Daniel Oyón, Anna Arnau, Lara M. Ruiz-Belmonte, Javier Tejedor-Tejada, Raul Zapater, Noelia Martín-Vicente, Pedro José Fernández-Esparcia, Ana Belén Julián Gomara, Violeta Sastre Lozano, Juan José Manzanares García, Irene Chivato Martín-Falquina, Laura Andrés Pascual, Nuria Torres Monclus, Natividad Zaragoza Velasco
-
Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-02-19 Jian-Jian Chen, Zhi-Cheng Jin, Bin-Yan Zhong, Wenzhe Fan, Wei-Hua Zhang, Biao Luo, Yu-Qing Wang, Gao-Jun Teng, Hai-Dong Zhu
Hepatocellular carcinoma (HCC) is one of the most common cancers and a leading cause of cancer-related mortality. Locoregional therapies (LRTs) play a crucial role in HCC management and are selectively adopted in real-world practice across various stages. Choosing the best form of LRTs depends on technical aspects, patient clinical status and tumour characteristics. Previous studies have consistently
-
Lymphocytic colitis can be transcriptionally divided into channelopathic and inflammatory lymphocytic colitis United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-02-17 Archana Bhardwaj, Andreas Münch, Julia Montague, Stefan Koch, Philip Rosenstiel, Celia Escudero-Hernández
-
Identifying predictors for comorbidities related mortality versus pancreatic cancer related mortality in patients with intraductal papillary mucinous neoplasm United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-02-17 Katsunori Sekine, Naoyoshi Nagata, Yuya Hisada, Kenjiro Yamamoto, Shuntaro Mukai, Takayoshi Tsuchiya, Akihiro Machitori, Yasushi Kojima, Tomoyuki Yada, Natsuyo Yamamoto, Naomi Uemura, Takao Itoi, Takashi Kawai
-
Point-shear wave elastography generated by acoustic radiation force impulse in chronic pancreatitis United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-02-16 Maximilian Wekerle, Katharina Murillo, Manuel vonBoscamp, Veronika Hauber, Matthias P. Ebert, Christoph Antoni, Michael Hirth
-
Recent developments in the management of ascites in cirrhosis United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-02-10 Tian Lan, Ming Chen, Chengwei Tang, Pierre Deltenre
In recent years, advances have been made for treating ascites in patients with cirrhosis. Recent studies have indicated that several treatments that have been used for a long time in the management of portal hypertension may have beneficial effects that were not previously identified. Long-term albumin infusion may improve survival in patients with cirrhosis and ascites while beta-blockers may reduce
-
How safe are opioids in the early phase of acute pancreatitis? United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-02-09 Naomi D. E. Thierens, Ihsan Ekin Demir
In the management of acute pancreatitis (AP), adequate pain management is crucial. Nonetheless, literature addressing this aspect of AP is limited. As a result, current guidelines on the management of AP provide only a few recommendations on this topic.1 In clinical practice, pain management for AP mimics the approach used for other painful conditions and local protocols. Opioids are often used as
-
Improved diagnosis of faecal incontinence in the gastroenterology domain: The time to act has come United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-02-08 Edoardo Vincenzo Savarino, Giuseppe Chiarioni
Faecal incontinence (FI) refers to recurring, uncontrolled leaking of solid or liquid stool for a period of at least 3 months in an individual with a developmental age of at least 4 years, according to the Rome Foundation for disorders of gut-brain interaction (DGBI).1 The definition has been rehearsed by the recently conveyed United European Gastroenterology Committee aiming to address all issues
-
Issue Information United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-02-12
No abstract is available for this article.
-
Patients with eosinophilic oesophagitis in Denmark have higher use of psychotropic drugs: A Danish nationwide study of psychotropic drug use in 3367 patients and 16,835 matched comparators United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-02-07 Andreas Kiesbye Øvlisen, Line Tegtmeier Frandsen, Martin Hollænder, Kasper Bredal, Jacob Holmen Terkelsen, Kristian Hay Kragholm, Christian Torp-Pedersen, Dorte Melgaard, Anne Lund Krarup
-
Psychological symptoms and quality of life in patients with inflammatory bowel disease in China: A multicenter study United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-02-05 Jixiang Zhang, Chuan Liu, Ping An, Min Chen, Yuping Wei, Jinting Li, Suqi Zeng, Dan Xiang, Yanhui Cai, Jun Li, Baili Chen, Liqian Cui, Jiaming Qian, Zhongchun Liu, Changqing Jiang, Jie Shi, Kaichun Wu, Weiguo Dong
-
Updated German guideline on diagnosis and treatment of squamous cell carcinoma and adenocarcinoma of the esophagus United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-01-29 Rainer Porschen, Wolfgang Fischbach, Ines Gockel, Stephan Hollerbach, Arnulf Hölscher, Petra Lynen Jansen, Stephan Miehlke, Oliver Pech, Michael Stahl, Udo Vanhoefer, Matthias P. A. Ebert
-
Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real-world efficacy from the EoE CONNECT registry United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-01-29 Emilio J. Laserna-Mendieta, Pilar Navarro, Sergio Casabona-Francés, Edoardo V. Savarino, Edurne Amorena, Isabel Pérez-Martínez, Danila Guagnozzi, Leonardo Blas-Jhon, Elena Betoré, Antonio Guardiola-Arévalo, Gaia Pellegatta, Anne Lund Krarup, Antonia Perello, Jesús Barrio, Carolina Gutiérrez-Junquera, Carlos Teruel Sánchez-Vegazo, Sonia Fernández-Fernández, Juan Enrique Naves, Salvatore Oliva, Juan
-
High vaccination coverage and infection rate result in a robust SARS-CoV-2-specific immunity in the majority of liver cirrhosis and transplant patients: A single-center cross-sectional study United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-01-27 P. von der Schulenburg, A. Herting, A. Harberts, M. Lütgehetmann, J. Jahnke-Triankowski, S. Pischke, F. Piecha, A. Drolz, V. Jörg, P. Hübener, M. Wehmeyer, M. M. Addo, L. Fischer, A. W. Lohse, J. Schulze Zur Wiesch, M. Sterneck
-
UEG Journal's impact and vision for the future United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-01-27 Omar Elshaarawy, Alberto Balduzzi, Anna Burelli, Zsa Zsa Weerts
INTRODUCTION The UEG Journal has become a leading international journal in gastroenterology during the past years and aims to be in the top 15% of gastroenterology journals worldwide, serving as a well-known forum for research on digestive diseases. We feel that this vision has come to pass as we commemorate the journal's 10th anniversary. Over these 10 years, The UEG Journal has received over 50,000
-
Autoimmune pancreatitis—New evidence for clinical management strategies United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-01-25 C. Ammer-Herrmenau, J. Hamm, A. Neesse
INTRODUCTION Autoimmune pancreatitis (AIP) is a rare inflammatory condition of the pancreas with an incidence of one case per 100,000 inhabitants in Europe.1 According to International Consensus Diagnostic Criteria, AIP is categorized into type 1, type 2, and not otherwise specified (NOS).2 While type 1 (male predominance) is considered as systemic IgG4 disease with common involvement of the bile duct
-
Systemic therapies in hepatocellular carcinoma: A revolution? United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-01-24 Marta Fortuny, Marco Sanduzzi-Zamparelli, Maria Reig
-
Incidence, characteristics, and predictive factors of post-colonoscopy colorectal cancer United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-01-17 Sandra Baile-Maxía, Carolina Mangas-Sanjuan, Noelia Sala-Miquel, Claudia Barquero, Germán Belda, Gloria García-del-Castillo, Antonio García-Herola, Juan Carlos Penalva, María-Dolores Picó, María-José Poveda, Félix de-Vera, Pedro Zapater, Rodrigo Jover
-
Clinical features and long-term outcomes of patients with type 2 autoimmune pancreatitis United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-01-12 Nicolò de Pretis, Michele Carlin, Emilia Calderini, Federico Caldart, Maria Cristina Conti Bellocchi, Antonio Amodio, Giulia De Marchi, Pietro Campagnola, Stefano Francesco Crinò, Laura Bernardoni, Armando Gabbrielli, Luigi Martinelli, Luca Frulloni
-
An intraprocedural bowel cleansing system for difficult-to-prepare patients—A multicenter prospective feasibility study United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-01-11 Milou L. M. van Riswijk, Kelly E. van Keulen, Helmut Neumann, Peter D. Siersema
-
Obesity and harmful alcohol consumption are predictors for advanced liver disease in the disease management program for type 2 diabetes United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-01-11 Maurice Michel, Michelle Doll, Nastasia Albert, Marc Morgenstern, Andreas Behr, Stefan Maxeiner, Christian Labenz, Peter R. Galle, Jörn M. Schattenberg
-
Lymph node metastases and recurrence in pT1 colorectal cancer: Prediction with the International Budding Consortium Score—A retrospective, multi-centric study United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-01-09 Heather Dawson, John-Melle Bokhorst, Linda Studer, Michael Vieth, Ayse Selcen Oguz Erdogan, Sonay Kus Öztürk, Richard Kirsch, Scarlett Brockmoeller, Gieri Cathomas, Rolf Buslei, David Fink, Marie Roumet, Inti Zlobec, Jeroen van der Laak, Iris D. Nagtegaal, Alessandro Lugli
-
Therapeutic management of metabolic dysfunction associated steatotic liver disease United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-01-09 Jing Zeng, Jian-Gao Fan, Sven M. Francque
-
Increased risk of obstructive lung disease in inflammatory bowel disease: A population-based cohort study United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-01-06 Henrik Albæk Jacobsen, Anastasia Karachalia Sandri, Ulla Møller Weinreich, Tine Jess, Lone Larsen
-
The assessment and management of cirrhotic patients with encephalopathy United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-01-05 H. Kibble, Debbie L. Shawcross
-
Metabolic dysfunction associated steatotic liver disease—Clinicians should not underestimate the role of steatosis United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-01-04 Johannes Wiegand, David Petroff, Thomas Karlas
All-cause mortality and incidence of liver related complications of metabolic dysfunction associated fatty liver disease (MASLD), formerly named nonalcoholic fatty liver disease (NAFLD), are mainly driven by the extent of liver fibrosis.1 Hepatic steatosis has been considered less relevant, however, recent data have shown that hepatic fat accumulation deserves more attention: (i) individuals with grade
-
The diagnostic yield of colonoscopic surveillance following resection of early age onset colorectal cancer United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-01-03 Husam Al Maliki, Kevin J. Monahan
-
UEG onwards & upwards: A president's perspective United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-01-05 J.-Matthias Löhr
Before I applied for the post of UEG Vice President, the world seemed to be in balance. Now, we have two wars ongoing and struggle with the sequelae of the COVID-19 pandemic. The heartbreak caused by the wars cannot be understated, as well as the terrible effect on everybody in our myUEG community and the severity of the long-term impacts of the pandemic regarding our profession.1 Long COVID is a reality
-
Correction to miR-10b-5p rescues leaky gut linked with gastrointestinal dysmotility and diabetes United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-01-05
Zogg H, Singh R, Ha SE, Wang Z, Jin B, Ha M, et al. miR-10b-5p rescues leaky gut linked with gastrointestinal dysmotility and diabetes. United European Gastroenterol J. 2023;11(8):750–766. 10.1002/ueg2.12463. The Y-axis values of blood glucose (mg/dL), “0, 10, 20, 30, and 40” in Figure (2b) were corrected to “0, 50, 100, 150, and 200”. The revised figure is given below: FIGURE 2 Open in figure viewerPowerPoint
-
SARS-Cov-2 vaccination is safe in autoimmune pancreatitis patients United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-01-05 Lukas Perkhofer, Katja Kilani, Ägädius Wieser, Thomas Seufferlein, Pauline Kleger, Martin Mueller, Alexander Kleger
Dear Editors, Recent studies have shed light on the significant connection of SARS-CoV-2 infection with a heightened risk of experiencing a wide range of newly emerging autoimmune conditions.1 Among others, SARS-CoV-2 has been associated with exacerbation of acute pancreatitis2 and new-onset diabetes, in line with viral infection of both endocrine and exocrine pancreatic cells.3 To what extent vaccines
-
Population-based birth cohort studies, a powerful design to identify childhood environmental risk factors for inflammatory bowel disease United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-01-04 Tereza Lerchova, Karl Mårild, Johnny Ludvigsson
Letter in Reply: We would like to thank Doctor Homsi for the feedback provided to our study.1 Despite the appreciation that the childhood environment can contribute to inflammatory bowel disease (IBD) risk, the nature and precise timing of such factors are largely unknown. This knowledge gap likely relates to a scarcity of large, unselected cohorts with long-term follow-ups needed to provide sufficient-powered
-
The Pivotal ‘P’s of inflammatory bowel disease: Prediction and Prevention United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2024-01-02 Dotan Yogev, Dan Turner
Despite numerous advancements in the treatment of inflammatory bowel diseases (IBDs), many patients still face a debilitating disease course with complications, surgeries and frequent periods of active disease.1, 2 Moreover, while the incidence of IBD has started to plateau in many Western countries, the prevalence continues to rise in all parts of the world, and is expected to surpass 1% in the near
-
Endoscopic management of duodenal perforation caused by foreign bodies in adults: A retrospective study United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2023-12-30 Li-Yun Ma, Zu-Qiang Liu, Ye Wang, Tao Wang, Guang-bin Sun, Li Wang, Ke-Yang Fan, Jing-Zheng Liu, Li-Li Ma, Wen-Zheng Qin, Jian-Wei Hu, Ming-Yan Cai, Guo-Liang Zhang, Quan-Lin Li, Ping-Hong Zhou
-
Rapidly achieving clinical remission in ulcerative colitis indicates better endoscopic and histological outcomes United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2023-12-30 Rirong Chen, Yizhe Tie, Yongle Huang, Xi Zhang, Zhirong Zeng, Minhu Chen, Li Li, Shenghong Zhang
-
Gut microbiota analysis in inflammatory bowel disease: Novel findings from old data United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2023-12-29 Irene Marafini, Giovanni Monteleone
The presence of altered gut microbiota, usually described as intestinal “dysbiosis,” has been widely documented in inflammatory bowel disease (IBD) and it is thought to influence the onset and perpetuation of gut inflammation both in Crohn's disease (CD) and ulcerative colitis (UC).1 Dysbiosis is characterized by the reduction of beneficial bacteria, overgrowth of potentially pathogenic bacteria, and
-
Predictors of controlled attenuation parameter in metabolic dysfunction United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2023-12-23 Cristiana Bianco, Serena Pelusi, Sara Margarita, Federica Tavaglione, Oveis Jamialahmadi, Francesco Malvestiti, Giulia Periti, Jessica Rondena, Melissa Tomasi, Rossana Carpani, Luisa Ronzoni, Matteo Vidali, Ferruccio Ceriotti, Mirella Fraquelli, Umberto Vespasiani-Gentilucci, Stefano Romeo, Daniele Prati, Luca Valenti
-
Risk factors associated with liver-related complications in diabetes: There may be more than meets the eye United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2023-12-19 Lukas Otero-Sanchez, Christophe Moreno
Over the past 2 decades, there has been a growing scientific interest regarding the relationship between diabetes and liver-related complications. To date, PubMed has indexed 44,334 papers encompassing the terms ‘diabetes’ and ‘liver disease’.1 Notably, over a quarter of these papers specifically focus on the interplay between diabetes and metabolic dysfunction-associated fatty liver disease (MASLD)
-
Exploring the links between types 2 diabetes and liver-related complications: A comprehensive review United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2023-12-16 Lukas Otero Sanchez, Yuping Chen, Guillaume Lassailly, Xiaolong Qi
-
Tight control using fecal calprotectin and early disease intervention increase the rates of transmural remission in Crohn's disease United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2023-12-13 Samuel Raimundo Fernandes, Sónia Bernardo, Sofia Saraiva, Ana Rita Gonçalves, Paula Moura Santos, Ana Valente, Luís Araújo Correia, Helena Cortez-Pinto, Fernando Magro
-
Issue Information United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2023-12-14
No abstract is available for this article.
-
The role of an integrated referral program for patients with liver disease: A network between hub and spoke centers United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2023-12-13 Giacomo Germani, Alberto Ferrarese, Francesca D’Arcangelo, Francesco Paolo Russo, Marco Senzolo, Martina Gambato, Alberto Zanetto, Umberto Cillo, Paolo Feltracco, Paolo Persona, Eugenio Serra, Giuseppe Feltrin, Giovanni Carretta, Alfio Capizzi, Daniele Donato, Michele Tessarin, Patrizia Burra
Access to Liver transplantation (LT) can be affected by several barriers, resulting in delayed referral and increased risk of mortality due to complications of the underlying liver disease.
-
Prevalence and temporal trend of gastric preneoplastic lesions in Asia: A systematic review with meta-analysis United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2023-12-12 Yunhao Li, Fang Jiang, Chun Ying Wu, Wai K. Leung
-
Childhood and adulthood passive and active smoking, and the ABO group as risk factors for pancreatic cancer in women United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2023-12-08 Anne-Laure Vedie, Nasser Laouali, Amandine Gelot, Gianluca Severi, Marie-Christine Boutron-Ruault, Vinciane Rebours
-
Atezolizumab and bevacizumab for non-resectable or metastatic combined hepatocellular-cholangiocarcinoma: A multicentric retrospective study United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2023-12-07 Elia Gigante, Mohamed Bouattour, José Ursic Bedoya, Hélène Regnault, Marianne Ziol, Eric Assenat, Valérie Paradis, Julien Calderaro, Nathalie Ganne-Carrié, Karine Bouhier-Leporrier, Giuliana Amaddeo, Jean Charles Nault
-
Inflammatory bowel diseases and eosinophilic oesophagitis: Two overlapping disorders? United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2023-12-08 Nathan Grellier, Julien Kirchgesner
Inflammatory bowel diseases (IBD) and eosinophilic oesophagitis (EoE) are immune-mediated disorders of the gastrointestinal (GI) tract with an increasing incidence worldwide.1, 2 Both diseases are characterised by a loss of tolerance towards luminal antigens favoured by microbiota disruption suggesting that they may share similar pathophysiology.3, 4 Associations between the two diseases have been
-
Eosinophilic esophagitis is associated with increased risk of later inflammatory bowel disease in a nationwide Swedish population cohort United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2023-12-07 Amiko M. Uchida, John J. Garber, Ashley Pyne, Kathryn Peterson, Bjorn Roelstraete, Ola Olén, Jonas Halfvarson, Jonas F. Ludvigsson
-
Splenic artery embolisation for splenic injury during colonoscopy: A systematic review United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2023-12-04 Matthew Lukies, Warren Clements
-
Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management United Eur. Gastroenterol. J. (IF 6.0) Pub Date : 2023-12-04 Manuel Pabón-Carrasco, Alma Keco-Huerga, Manuel Castro-Fernández, Ilaria Maria Saracino, Giulia Fiorini, Dino Vaira, Ángeles Pérez-Aísa, Bojan Tepes, Laimas Jonaitis, Irina Voynovan, Alfredo J. Lucendo, Ángel Lanas, Samuel J. Martínez-Domínguez, Enrique Alfaro Almajano, Luis Rodrigo, Ludmila Vologzanina, Natasa Brglez Jurecic, Maja Denkovski, Luis Bujanda, Rustam A. Abdulkhakov, Jose M. Huguet, Luis